Vertex Pharmaceuticals (VRTX) Assets Average (2010 - 2026)

Vertex Pharmaceuticals has reported Assets Average for 17 years, with the latest figure at $27.0 billion in Q2 2026.

• On a quarterly basis, Assets Average rose 14.9% year-over-year to $27.0 billion in Q2 2026; TTM through Jun 2026 was $27.0 billion, a 14.9% increase from a year earlier, with the FY2025 full-year figure at $24.1 billion, up 6.44% from the prior year.
• Assets Average was $27.0 billion for Q2 2026 at Vertex Pharmaceuticals, up from $26.1 billion in the prior quarter.
• The five-year high for Assets Average was $27.0 billion in Q2 2026, with the low at $13.8 billion in Q1 2022.
• Average Assets Average over 5 years is $21.2 billion, with a median of $22.1 billion recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Assets Average jumped 34.08% in 2023, then fell 2.65% in 2025.
• Over 5 years, Assets Average stood at $17.4 billion in 2022, then advanced by 27.54% to $22.2 billion in 2023, then rose by 0.71% to $22.4 billion in 2024, then climbed by 12.8% to $25.3 billion in 2025, then gained by 6.74% to $27.0 billion in 2026.
• The last three Assets Average figures came in at $27.0 billion (Q2 2026), $26.1 billion (Q1 2026), and $25.3 billion (Q4 2025), per Business Quant data.